Shopping Cart
Remove All
Your shopping cart is currently empty
ADG-106 is a fully human monoclonal antibody targeting CD137 (4-1BB). It activates CD137 via potent FcγRIIB-mediated cross-linking, antagonising CD137 ligands, and may be employed for anti-tumour immunotherapy.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $380 | - | In Stock | |
| 5 mg | $933 | - | In Stock | |
| 10 mg | $1,250 | - | In Stock | |
| 25 mg | $1,860 | - | In Stock |
| Description | ADG-106 is a fully human monoclonal antibody targeting CD137 (4-1BB). It activates CD137 via potent FcγRIIB-mediated cross-linking, antagonising CD137 ligands, and may be employed for anti-tumour immunotherapy. |
| Synonyms | ADG106 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | TNFRSF9/4-1BB/CD137 |
| Molecular Weight | 144.72 kDa |
| Isotype | Human IgG4 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.